Cancer/Tumor Profiling Market Analysis Report By Technology, By Application , By Technique And Forecasts, 2018 – 2025: Grand View Research Inc.

Cancer/Tumor Profiling Market Analysis Report By Technology, By Application , By Technique And Forecasts, 2018 - 2025: Grand View Research Inc.

Grand View Research, Inc. – Market Research And Consulting.
According to report published by Grand View Research, The global cancer/tumor profiling market size was estimated at USD 10.73 billion in 2017 and is expected to register a CAGR of 8.8% during the forecast period.

The global cancer/tumor profiling market size is expected to reach USD 21.08 billion by 2025, exhibiting a CAGR of 8.8%, according to a new report by Grand View Research, Inc. Rising research in the application of omics sciences in cancer detection is anticipated to influence market growth.

Technological advances in biotechnology have allowed for deeper insights into metabolism and gene expression. These have accelerated the application of advanced techniques such as metabolomics and epigenetics in cancer screening and detection. Thus, demand for cancer tumor/profiling (CTP) techniques is anticipated to witness lucrative growth with the expansion of downstream applications.

Cancer tumor profiling is a potential procedure through which cancer can be detected and studied further to identify the stage, metabolism, and changes in morphology of the tumor. This aids in routine diagnostics as well as therapeutic decision-making. Tumor profiling has significant importance in developing therapies aimed at a specific individual, based on the severity of ailment and genomic build up of the individual.

Enhanced detection and sequencing techniques such as NGS and in-situ hybridization can help speed up the cancer tumor profiling process and are estimated to gain much traction over the coming years. Their high adoption is attributive to accelerated speed in gaining results with minimum resources and greater accuracy.

Germany cancer/tumor profiling market size, by technique, 2014 - 2025 (USD Million)

Request a sample Copy of the Cancer/Tumor Profiling Market Research Report @

Key Takeways Of The Report :

  • Personalized cancer medicine is expected to be the most lucrative application segment for CTP adoption. The segment is expected to fuel exhibit a CAGR of over 9.0%
  • Owing to difference in usage of and interdependency of functional information from genomic, epigenomic, and metabolomic analysis of cancer cells, it can be expected that these technology segments will grow in tandem with each other and exhibit lucrative growth over the forecast years
  • Asia Pacific is projected to witness substantial growth over the next decade owing to various developments across major economies, with increased focus of dominant players in emerging economies as well
  • Key players include Illumina, Inc.; Qiagen N.V.; Neogenomics Laboratories Inc.; HTG Molecular Diagnostics, Inc.; Genomic Health Inc.; Caris Life Sciences Helomics Corporation; Nanostring Technologies; Oxford Gene Technology; Ribomed Biotechnologies, Inc.; Personal Genome Diagnostics; GenomeDX; Guardant Health; and Foundation Medicine.

Global cancer/tumor profiling market share, by technology, 2017 (%)

Have Any Query? Ask Our Experts @

Grand View Research has segmented the global cancer/tumor profiling market on the basis of technology, technique, application, and region:

Cancer/Tumor Profiling Technique Outlook (Revenue, USD Million, 2014 – 2025)

  • Genomics
  • Proteomics
  • Metabolomics
  • Epigenetics

Cancer/Tumor Profiling Technology Outlook (Revenue, USD Million, 2014 – 2025)

  • Sequencing Techniques
    • Next-generation Sequencing
    • Sanger Sequencing
    • Pyro Sequencing
  • In Situ Hybridization
  • Immunohistochemistry
  • Quantitative PCR
  • Microarray

Cancer/Tumor Profiling Application Outlook (Revenue, USD Million, 2014 – 2025)

  • Personalized Cancer Medicine
  • Oncological Diagnostics
  • Research
    • Cancer Research
    • Biomarker Discovery

Cancer/Tumor Profiling Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
  • Asia Pacific
    • China
    • Japan
  • Latin America
    • Brazil
  • Middle East & Africa
    • South Africa

Browse Related Report:

Scaffold Technology Market :

Bone Morphogenetic Protein Market :

About Grand View Research

Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.


Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: United States